Employees Retirement System of Texas’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-172,165
| Closed | -$654K | – | 793 |
|
|
2020
Q1 | $654K | Hold |
172,165
| – | – | 0.01% | 657 |
|
|
2019
Q4 | $876K | Hold |
172,165
| – | – | 0.01% | 718 |
|
|
2019
Q3 | $870K | Buy |
172,165
+45,165
| +36% | +$228K | 0.01% | 748 |
|
|
2019
Q2 | $784K | Sell |
127,000
-83,000
| -40% | -$512K | 0.01% | 855 |
|
|
2019
Q1 | $974K | Hold |
210,000
| – | – | 0.01% | 814 |
|
|
2018
Q4 | $882K | Hold |
210,000
| – | – | 0.01% | 826 |
|
|
2018
Q3 | $1.32M | Buy |
210,000
+71,000
| +51% | +$445K | 0.02% | 768 |
|
|
2018
Q2 | $1.12M | Buy |
139,000
+25,000
| +22% | +$201K | 0.02% | 822 |
|
|
2018
Q1 | $850K | Hold |
114,000
| – | – | 0.01% | 856 |
|
|
2017
Q4 | $678K | Hold |
114,000
| – | – | 0.01% | 919 |
|
|
2017
Q3 | $839K | Buy |
114,000
+32,000
| +39% | +$236K | 0.01% | 856 |
|
|
2017
Q2 | $557K | Buy |
+82,000
| New | +$557K | 0.01% | 933 |
|